Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001411726-08-000009
Filing Date
2008-04-16
Accepted
2008-04-16 17:19:29
Documents
1
Period of Report
2008-04-14

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 6201
  Complete submission text file 0001411726-08-000009.txt   8170
Mailing Address 2850 TELEGRAPH AVENUE SUITE 310 BERKELEY CA 94705
Business Address 2850 TELEGRAPH AVENUE SUITE 310 BERKELEY CA 94705 (510) 281-7700
Nile Therapeutics, Inc. (Issuer) CIK: 0001133869 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address NILE THERAPEUTICS, INC. 2850 TELEGRAPH AVE., SUITE #310 BERKELEY CA 94705
Business Address (510) 281 - 7701
Strumph Peter M (Reporting) CIK: 0001411725 (see all company filings)

Type: 4 | Act: 34 | File No.: 333-55166 | Film No.: 08760498